Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: Accuracy as determined by 2 independent observers

Journal of Nuclear Medicine

Volumn 44, Issue 3, 2003, Pages 336-340

  Stevens, Henk ^a   Bakker, Patricia F A ^a   Schlösser, Noël J J ^a   Van Rijk, Peter P ^a   De Klerk, John M H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

18F FDG; Dual head coincidence camera; Interobserver variability; Mediastinal staging; Non small cell lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CAMERA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INJECTION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PRIORITY JOURNAL; TIME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LUNG TUMOR; LYMPH NODE; MIDDLE AGED; OBSERVER VARIATION; PREDICTION AND FORECASTING; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTILLATION CAMERA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037361744     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fry WA, Menck HR, Winchester DP. The national cancer data base report on lung cancer Cancer 1996;77:1947-1955
2. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Arch Intern Med. 1997;157:849-855
3. Webb WR Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705-713.
4. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL Metastases from non-small cell lung cancer, mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology. 1999,213:530-536.
5. Gould MK, Maclean CC, Kuschner WO, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914-924
6. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254-261.
7. 18F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy, impact on management and prognostic stratification. J Nucl Med. 2001;42:1605-1613.
8. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer J Nucl Med. 2001;42:1596-1604.
9. 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med. 2001;28:763-778.
10. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head position emission tomography Eur J Nucl Med. 1999;26:767-773
11. Stokkel MP, ten Broek FW, van Rijk PP Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study. Eur J Nucl Med 1999;26:499-503.
12. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-1723
13. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997,111:1710-1717.
14. Bousson V, Moretti JL, Weinmann P, et al. Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement. J Nucl Med. 2000;41:1801-1807.
15. Tatsumi M, Yutani K, Watanabe Y. et al. Feasibiliry of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med. 1999;40.566-573.
16. 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med. 1999;40.574-578.
17. Weber WA, Neverve J, Sklarek J, et al. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system. Eur J Nucl Med 1999;26:388-395.
18. Dietlein M, Weber K, Gandjou A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med. 2000.27:1441-1456.
19. Gambhir SS, Shepherd JE, Shah BD. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol. 1998;16:2113-2125.
20. Scott WJ, Shepherd J, Gambhir SS. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg. 1998;66:1876-1883.
21. Dietlein M, Weber K, Gandjour A, et al Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med. 2000;27:1598-1609.
22. Shreve P, Stevenson R, Gross M, Wahl R. Lesion detection in oncologic diagnosis: comparison of dual head coincidence with dedicated PET FDG imaging [abstract]. J Nucl Med. 1998;39(suppl):109P.
23. Stokkel MP, Bakker PF, Heine R, Schlosser NJ, Lammers JW, van Rijk PP. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer. Nucl Med Commun. 1999;20 1001-1007.
24. Bengel FM, Ziegler SI, Avril N, Weber W, Laudenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology, comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med. 1997;24:1091-1098.
25. Kotzerke J, Guhlman A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med. 1999;26:31-38
26. Zimny M, Kaiser HJ, Cremerius U, et al. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection. Eur J Nucl Med. 1999;26:818-823.
27. Chan W-L, Freund J, Pocock NA, et al. Coincidence detection FDG PET in the management of oncological patients: attenuation correction versus non-attenuation correction. Nucl Med Commun. 2001;22:1185-1192.